Bank of New York Mellon Corp trimmed its position in National Health Investors, Inc. (NYSE:NHI – Get Rating) by 0.1% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 817,425 shares of the real estate investment trust’s stock after selling 1,042 shares during the quarter. Bank of New York Mellon Corp owned 1.78% of National Health Investors worth $48,236,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Covestor Ltd acquired a new position in National Health Investors in the 4th quarter valued at $33,000. TCI Wealth Advisors Inc. grew its holdings in shares of National Health Investors by 566.0% during the 1st quarter. TCI Wealth Advisors Inc. now owns 706 shares of the real estate investment trust’s stock worth $42,000 after purchasing an additional 600 shares in the last quarter. Financial Advantage Inc. acquired a new stake in shares of National Health Investors during the 1st quarter worth $59,000. Mitsubishi UFJ Trust & Banking Corp grew its holdings in shares of National Health Investors by 232.1% during the 4th quarter. Mitsubishi UFJ Trust & Banking Corp now owns 1,003 shares of the real estate investment trust’s stock worth $57,000 after purchasing an additional 701 shares in the last quarter. Finally, Stonebridge Capital Advisors LLC acquired a new stake in shares of National Health Investors during the 4th quarter worth $77,000. 65.25% of the stock is owned by institutional investors and hedge funds.
National Health Investors Stock Performance
NYSE:NHI opened at $64.14 on Monday. The stock’s 50-day simple moving average is $63.35 and its 200 day simple moving average is $58.89. The firm has a market capitalization of $2.86 billion, a PE ratio of 43.93 and a beta of 0.88. The company has a quick ratio of 12.92, a current ratio of 12.92 and a debt-to-equity ratio of 0.79. National Health Investors, Inc. has a twelve month low of $50.22 and a twelve month high of $67.16.
National Health Investors Dividend Announcement
Wall Street Analyst Weigh In
Several research firms have recently issued reports on NHI. BMO Capital Markets lowered National Health Investors from an “outperform” rating to a “market perform” rating and set a $62.00 target price on the stock. in a report on Tuesday, June 21st. Credit Suisse Group started coverage on National Health Investors in a report on Wednesday, June 22nd. They set an “underperform” rating on the stock. Finally, Capital One Financial started coverage on National Health Investors in a research note on Friday, June 3rd. They issued an “overweight” rating and a $64.00 price objective on the stock. One analyst has rated the stock with a sell rating, three have assigned a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, National Health Investors has an average rating of “Hold” and an average price target of $60.25.
Insider Buying and Selling at National Health Investors
In other news, Director Robert G. Adams bought 1,500 shares of the company’s stock in a transaction on Monday, August 15th. The stock was purchased at an average cost of $65.93 per share, for a total transaction of $98,895.00. Following the completion of the transaction, the director now owns 85,411 shares of the company’s stock, valued at $5,631,147.23. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. Corporate insiders own 7.26% of the company’s stock.
National Health Investors Company Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
- Get a free copy of the StockNews.com research report on National Health Investors (NHI)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.